Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion type Assertion NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_head.
- NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion description "[Although no relation between plasma IGF-I levels and IGF-I genotypes was found, women who carried the genotypes containing the (CA)17 or (CA)19 allele were associated with a significantly decreased (OR = 0.80, 95% CI: 0.64-1.00) or increased (OR = 1.23, 95% CI: 1.04-1.47) risk of breast cancer, respectively, and women who carried the genotypes containing any of the 4 rare alleles, (CA)11, (CA)13, (CA)16 and (CA)23, were associated with a nonsignificantly increased risk of breast cancer (OR = 1.92, 95% CI: 0.92-4.02) compared to those who did not carry the specific alleles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_provenance.
- NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion evidence source_evidence_literature NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_provenance.
- NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion SIO_000772 15386404 NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_provenance.
- NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion wasDerivedFrom befree-20140225 NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_provenance.
- NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_assertion wasGeneratedBy ECO_0000203 NP934091.RALWy44eqSnvckaZ-K2Z0rb2f7eciVKpsD97b9O85-b7g130_provenance.